|
2024-10-11 |
2024-10-11 |
PS
Planned sale
|
DIAZ PAUL J
President and CEO
Executive Director
|
15,000
-1.5%
22.93
USD 343,950
|
15,000
-1.5%
|
22.93
|
USD 343,950
|
|
|
2024-09-12 |
2024-09-11 |
PS
Planned sale
|
DIAZ PAUL J
President and CEO
Executive Director
|
15,000
-1.5%
26.72
USD 400,800
|
15,000
-1.5%
|
26.72
|
USD 400,800
|
|
|
2024-09-12 |
2024-09-11 |
S
Sale
|
Muzzey Dale
Chief Scientific Officer
Officer
|
2,100
-1.9%
26.17
USD 54,961
|
2,100
-1.9%
|
26.17
|
USD 54,961
|
|
|
2024-09-09 |
2024-09-09 |
S
Sale
|
Dreismann Heinrich
Non-Executive Director
|
10,000
-7.6%
27.05
USD 270,520
|
10,000
-7.6%
|
27.05
|
USD 270,520
|
|
|
2024-09-04 |
2024-09-03 |
PS
Planned sale
|
Reitan Colleen F
Non-Executive Director
|
46,012
-52.0%
27.95
USD 1,285,851
|
46,012
-52.0%
|
27.95
|
USD 1,285,851
|
|
|
2024-08-23 |
2024-08-21 |
S
Sale
|
Ancona Margaret
SVP, Chief of Staff
Officer
|
11,538
-12.7%
27.82
USD 320,987
|
11,538
-12.7%
|
27.82
|
USD 320,987
|
|
|
2024-08-20 |
2024-08-19 |
PS
Planned sale
|
Kumar Rashmi
Non-Executive Director
|
7,500
-8.8%
28.01
USD 210,075
|
7,500
-8.8%
|
28.01
|
USD 210,075
|
|
|
2024-06-04 |
2024-06-04 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
3,788
-10.3%
22.05
USD 83,525
|
3,788
-10.3%
|
22.05
|
USD 83,525
|
|
|
2024-06-04 |
2024-06-03 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
3,788
-9.4%
22.04
USD 83,488
|
3,788
-9.4%
|
22.04
|
USD 83,488
|
|
|
2024-05-15 |
2024-05-15 |
S
Sale
|
DIAZ PAUL J
President and CEO
Executive Director
|
75,000
-6.6%
25.07
USD 1,880,415
|
75,000
-6.6%
|
25.07
|
USD 1,880,415
|
|
|
2024-05-15 |
2024-05-14 |
S
Sale
|
DIAZ PAUL J
President and CEO
Executive Director
|
95,000
-7.7%
25.21
USD 2,394,798
|
95,000
-7.7%
|
25.21
|
USD 2,394,798
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Newcomer Lee Nisley
Non-Executive Director
|
6,200
-8.5%
25.30
USD 156,860
|
6,200
-8.5%
|
25.30
|
USD 156,860
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
DIAZ PAUL J
President and CEO
Executive Director
|
57,844
-4.5%
25.13
USD 1,453,550
|
57,844
-4.5%
|
25.13
|
USD 1,453,550
|
|
|
2023-12-05 |
2023-12-01 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
30,000
-9.3%
19.09
USD 572,835
|
30,000
-9.3%
|
19.09
|
USD 572,835
|
|
|
2023-11-03 |
2023-11-01 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
30,000
-8.5%
15.69
USD 470,622
|
30,000
-8.5%
|
15.69
|
USD 470,622
|
|
|
2023-06-02 |
2023-06-02 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
8,638
-17.6%
23.01
USD 198,760
|
8,638
-17.6%
|
23.01
|
USD 198,760
|
|
|
2023-03-28 |
2023-03-27 |
PS
Planned sale
|
Lambert Nicole
Chief Operating Officer
Officer
|
6,433
-2.6%
23.48
USD 151,047
|
6,433
-2.6%
|
23.48
|
USD 151,047
|
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Lambert Nicole
Chief Operating Officer
Officer
|
13,184
-5.8%
22.74
USD 299,823
|
13,184
-5.8%
|
22.74
|
USD 299,823
|
|
|
2023-03-03 |
2023-03-02 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
15,000
-4.3%
22.55
USD 338,253
|
15,000
-4.3%
|
22.55
|
USD 338,253
|
|
|
2023-01-23 |
2023-01-20 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
9,400
-2.5%
20.04
USD 188,386
|
9,400
-2.5%
|
20.04
|
USD 188,386
|
|
|
2023-01-19 |
2023-01-18 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
600
-0.2%
20.01
USD 12,006
|
600
-0.2%
|
20.01
|
USD 12,006
|
|
|
2022-12-28 |
2022-12-27 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
20,000
-5.1%
15.15
USD 302,992
|
20,000
-5.1%
|
15.15
|
USD 302,992
|
|
|
2022-06-06 |
2022-06-06 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
6,424
-15.9%
19.25
USD 123,673
|
6,424
-15.9%
|
19.25
|
USD 123,673
|
|
|
2022-03-01 |
2022-02-28 |
PS
Planned sale
|
Hart Jayne B.
Chief People Officer
Officer
|
3,500
-2.1%
25.00
USD 87,500
|
3,500
-2.1%
|
25.00
|
USD 87,500
|
|
|
2022-03-01 |
2022-02-28 |
PS
Planned sale
|
Hart Jayne B.
Chief People Officer
Officer
|
7,000
-4.0%
25.00
USD 175,000
|
7,000
-4.0%
|
25.00
|
USD 175,000
|
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
Lambert Nicole
See Remarks
Officer
|
1,420
-0.8%
31.57
USD 44,835
|
1,420
-0.8%
|
31.57
|
USD 44,835
|
|
|
2021-09-27 |
2021-09-27 |
PS
Planned sale
|
Lambert Nicole
See Remarks
Officer
|
10,112
-5.4%
33.10
USD 334,747
|
10,112
-5.4%
|
33.10
|
USD 334,747
|
|
|
2021-09-27 |
2021-09-23 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
200
-0.1%
35.06
USD 7,012
|
200
-0.1%
|
35.06
|
USD 7,012
|
|
|
2021-08-05 |
2021-08-04 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
11,775
-4.8%
35.57
USD 418,856
|
11,775
-4.8%
|
35.57
|
USD 418,856
|
|
|
2021-08-05 |
2021-08-04 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
38,225
-14.1%
35.24
USD 1,347,171
|
38,225
-14.1%
|
35.24
|
USD 1,347,171
|
|
|
2021-08-05 |
2021-08-03 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
4,170
-1.8%
34.00
USD 141,780
|
4,170
-1.8%
|
34.00
|
USD 141,780
|
|
|
2021-08-05 |
2021-08-03 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
27,830
-10.7%
34.00
USD 946,220
|
27,830
-10.7%
|
34.00
|
USD 946,220
|
|
|
2021-08-05 |
2021-08-03 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
1,775
-0.8%
35.07
USD 62,249
|
1,775
-0.8%
|
35.07
|
USD 62,249
|
|
|
2021-08-05 |
2021-08-03 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
16,225
-6.5%
33.99
USD 551,488
|
16,225
-6.5%
|
33.99
|
USD 551,488
|
|
|
2021-06-28 |
2021-06-25 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
33,372
-12.5%
31.61
USD 1,055,036
|
33,372
-12.5%
|
31.61
|
USD 1,055,036
|
|
|
2021-06-28 |
2021-06-25 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
28,640
-9.7%
31.97
USD 915,621
|
28,640
-9.7%
|
31.97
|
USD 915,621
|
|
|
2021-06-28 |
2021-06-25 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
21,360
-7.4%
32.47
USD 693,559
|
21,360
-7.4%
|
32.47
|
USD 693,559
|
|
|
2021-06-17 |
2021-06-17 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
3,139
-11.9%
30.52
USD 95,795
|
3,139
-11.9%
|
30.52
|
USD 95,795
|
|
|
2021-06-01 |
2021-05-28 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
Non-Executive Director
|
7,142
-34.7%
28.99
USD 207,023
|
7,142
-34.7%
|
28.99
|
USD 207,023
|
|
|
2021-05-05 |
2021-05-04 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
19,360
-6.8%
31.97
USD 618,949
|
19,360
-6.8%
|
31.97
|
USD 618,949
|
|
|
2021-04-28 |
2021-04-27 |
PS
Planned sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
40,000
-13.1%
31.47
USD 1,258,800
|
40,000
-13.1%
|
31.47
|
USD 1,258,800
|
|
|
2021-03-30 |
2021-03-29 |
PS
Planned sale
|
Hart Jayne B.
Chief People Officer
Officer
|
8,034
-9.1%
30.00
USD 241,020
|
8,034
-9.1%
|
30.00
|
USD 241,020
|
|
|
2021-03-30 |
2021-03-29 |
PS
Planned sale
|
Hart Jayne B.
Chief People Officer
Officer
|
21,966
-21.5%
30.00
USD 658,980
|
21,966
-21.5%
|
30.00
|
USD 658,980
|
|
|
2021-03-30 |
2021-03-29 |
PS
Planned sale
|
Hart Jayne B.
Chief People Officer
Officer
|
28,000
-25.9%
30.00
USD 840,000
|
28,000
-25.9%
|
30.00
|
USD 840,000
|
|
|
2021-02-17 |
2021-02-16 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
5,555
-2.2%
29.71
USD 165,056
|
5,555
-2.2%
|
29.71
|
USD 165,056
|
|
|
2021-02-17 |
2021-02-16 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
74,445
-23.2%
29.71
USD 2,211,992
|
74,445
-23.2%
|
29.71
|
USD 2,211,992
|
|
|
2021-01-11 |
2021-01-08 |
PS
Planned sale
|
Parkinson Paul
EVP Strategy and Innovation
Officer
|
11,824
-13.3%
25.00
USD 295,600
|
11,824
-13.3%
|
25.00
|
USD 295,600
|
|
|
2020-11-12 |
2020-11-11 |
B
Purchase
|
Phanstiel S. Louise
Non-Executive Director
|
15,000
+29.0%
16.62
USD 249,336
|
15,000
+29.0%
|
16.62
|
USD 249,336
|
|
|
2020-09-16 |
2020-09-15 |
S
Sale
|
Ford Alexander
Chief Operating Officer
Officer
|
2,804
-1.8%
13.78
USD 38,630
|
2,804
-1.8%
|
13.78
|
USD 38,630
|
|
|
2020-02-12 |
2020-02-12 |
S
Sale
|
Lambert Nicole
President, MGL
Officer
|
4,354
-6.9%
19.73
USD 85,915
|
4,354
-6.9%
|
19.73
|
USD 85,915
|
|
|
2020-02-07 |
2020-02-05 |
PS
Planned sale
|
Ford Alexander
President, MWH
Officer
|
7,273
-4.9%
30.00
USD 218,190
|
7,273
-4.9%
|
30.00
|
USD 218,190
|
|
|
2019-12-16 |
2019-12-13 |
B
Purchase
|
GILBERT WALTER PHD
Non-Executive Director
|
5,860
+12.1%
25.60
USD 149,998
|
5,860
+12.1%
|
25.60
|
USD 149,998
|
|
|
2019-11-07 |
2019-11-07 |
B
Purchase
|
HENDERSON JOHN T
|
1,750
+583.3%
23.46
USD 41,056
|
1,750
+583.3%
|
23.46
|
USD 41,056
|
|
|
2019-11-07 |
2019-11-07 |
B
Purchase
|
HENDERSON JOHN T
|
5,250
+8.9%
23.46
USD 123,167
|
5,250
+8.9%
|
23.46
|
USD 123,167
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
King Gary A.
Exec. VP International Ops
Officer
|
20,000
-12.9%
39.44
USD 788,810
|
20,000
-12.9%
|
39.44
|
USD 788,810
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
King Gary A.
Exec. VP International Ops
Officer
|
10,000
-6.9%
43.48
USD 434,816
|
10,000
-6.9%
|
43.48
|
USD 434,816
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
King Gary A.
Exec. VP International Ops
Officer
|
30,000
-18.2%
46.19
USD 1,385,703
|
30,000
-18.2%
|
46.19
|
USD 1,385,703
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
3,862
-0.9%
44.00
USD 169,928
|
3,862
-0.9%
|
44.00
|
USD 169,928
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
58,138
-11.7%
44.00
USD 2,558,072
|
58,138
-11.7%
|
44.00
|
USD 2,558,072
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
4,328
-1.0%
44.00
USD 190,432
|
4,328
-1.0%
|
44.00
|
USD 190,432
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
70,672
-13.8%
44.00
USD 3,109,568
|
70,672
-13.8%
|
44.00
|
USD 3,109,568
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Riggsbee Richard Bryan
Chief Financial Officer
Officer
|
25,000
-17.2%
41.50
USD 1,037,575
|
25,000
-17.2%
|
41.50
|
USD 1,037,575
|
|
|
2019-08-02 |
2019-08-01 |
PS
Planned sale
|
Tobin Bernard
President Crescendo BioScience
Officer
|
11,712
-7.4%
40.00
USD 468,480
|
11,712
-7.4%
|
40.00
|
USD 468,480
|
|
|
2019-03-12 |
2019-03-12 |
S
Sale
|
McDade Ralph L
President Myriad RBM, Inc.
|
1,975
-1.6%
31.00
USD 61,225
|
1,975
-1.6%
|
31.00
|
USD 61,225
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
2,346
-0.7%
41.00
USD 96,186
|
2,346
-0.7%
|
41.00
|
USD 96,186
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
Capone Mark Christopher
President & C.E.O.
Officer
|
77,654
-18.9%
41.00
USD 3,183,814
|
77,654
-18.9%
|
41.00
|
USD 3,183,814
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
3,861
-2.7%
43.34
USD 167,339
|
3,861
-2.7%
|
43.34
|
USD 167,339
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
Officer
|
46,139
-24.9%
43.34
USD 1,999,701
|
46,139
-24.9%
|
43.34
|
USD 1,999,701
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
MARSH RICHARD M
E.V.P., General Counsel
Officer
|
40,000
-24.4%
42.02
USD 1,680,652
|
40,000
-24.4%
|
42.02
|
USD 1,680,652
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
MARSH RICHARD M
E.V.P., General Counsel
Officer
|
30,672
-19.8%
44.00
USD 1,349,568
|
30,672
-19.8%
|
44.00
|
USD 1,349,568
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
HENDERSON JOHN T
Non-Executive Director
|
10,000
-16.7%
40.17
USD 401,700
|
10,000
-16.7%
|
40.17
|
USD 401,700
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
HENDERSON JOHN T
Non-Executive Director
|
10,000
-16.7%
42.01
USD 420,085
|
10,000
-16.7%
|
42.01
|
USD 420,085
|
|
|
2018-07-13 |
2018-07-11 |
S
Sale
|
HENDERSON JOHN T
Non-Executive Director
|
10,000
-16.7%
44.00
USD 440,000
|
10,000
-16.7%
|
44.00
|
USD 440,000
|
|
|
2018-06-19 |
2018-06-18 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
|
2,346
-1.7%
40.12
USD 94,122
|
2,346
-1.7%
|
40.12
|
USD 94,122
|
|
|
2018-06-19 |
2018-06-18 |
S
Sale
|
LANCHBURY JERRY S
Chief Scientific Officer
|
57,654
-29.3%
40.12
USD 2,313,078
|
57,654
-29.3%
|
40.12
|
USD 2,313,078
|
|
